Ribosomal protein L32 pseudogene 36 (RPL32P36)

Ribosomal protein L32 pseudogene 36 (RPL32P36) is a processed pseudogene in the human genome annotated as RPL32P36 or RPL32_24_1772[1][3][6]. It does not encode a functional protein and is not implicated in protein synthesis or other canonical ribosomal activities. Pseudogenes like RPL32P36 are characterized by sequence similarity to known protein-coding genes but typically lack coding potential due to mutations or lack of regulatory elements[3]. The parental gene is ribosomal protein L32 (RPL32), a structural constituent of the 60S ribosomal subunit, but RPL32P36 itself is not a functional ribosomal protein. There are no established therapeutic, diagnostic, or mechanistic roles for RPL32P36. RPL32P36 is not a protein, enzyme, receptor, transporter, or other classical therapeutic target[3]. It is classified as a pseudogene, which refers to gene sequences that resemble known genes but are generally nonfunctional[3]. No evidence links RPL32P36 to disease processes, drug interactions, or use in biomarker panels[1][3][6]. There is a general risk of confusing pseudogenes like RPL32P36 with their parental functional genes (e.g., RPL32) or with other pseudogene variants that may have regulatory noncoding RNA functions (for example, RPL32P3 has been studied for regulatory roles in glioma and blood–tumor barrier permeability[5], but this is not the same as RPL32P36). No published research identifies RPL32P36 as therapeutically or biologically relevant beyond its annotation as a pseudogene[1][3][6].

Other names

RPL32_24_1772